| Financial Year |
March 31 2023 |
| Monetary Funds |
1,345,734,804.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,566,034.18 |
| Accounts Receivable |
1,435,786,028.63 |
| Advances to Suppliers |
520,199,989.49 |
| Other Receivables |
142,428,509.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
27,535,293.35 |
| Inventories |
3,177,217,428.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
134,243,440.80 |
| Total Current Assets |
6,764,492,988.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,547,505,274.41 |
| Investment Properties |
-- |
| Fixed Assetes |
3,748,883,704.27 |
| Under-construction Projects |
289,626,991.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
198,377,669.56 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
370,298,239.75 |
| R&D expenses |
-- |
| Goodwill |
290,425.67 |
| Long-Term Deferred and Prepaid Expenses |
74,596,387.47 |
| Deferred Income Tax Assets |
56,683,754.04 |
| Other Non-Current Assets |
650,808,703.37 |
| Sub-Total of Non-Current Assets |
8,257,366,145.54 |
| Total Assets |
15,021,859,133.78 |
| Short-Term Loans |
1,125,443,021.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,511,073,431.49 |
| Accounts Received In Advance |
21,688,324.33 |
| Employee Compensation Payable |
108,765,533.33 |
| Taxes Payable |
29,866,309.31 |
| Interest Payable |
4,230,236.78 |
| Dividend Payable |
4,107,420.00 |
| Other payables |
493,172,059.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
412,973,235.66 |
| Other Current Liabilities |
2,344,652.88 |
| Sub-Total of Current Liabilities |
3,913,269,890.27 |
| Long-term Loans |
1,208,993,515.72 |
| Bonds Payable |
1,270,275,941.16 |
| Long-Term Accounts Payable |
8,957,311.79 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,497,558.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,792,418,909.76 |
| Total Liabilities |
6,705,688,800.03 |
| Paid-In Capital(Or Share Stock) |
919,430,450.00 |
| Capital Surplus |
881,613,200.69 |
| Surplus Reserve |
454,175,320.97 |
| LESS:Treasury Stock |
200,003,612.37 |
| Undistributed Profits |
4,988,121,824.96 |
| Minority Stockholder's Interest |
1,056,937,388.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,259,232,944.88 |
| Owner's Equity（Stockholder's Equity） |
8,316,170,333.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,021,859,133.78 |
